• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ANTI-CCP; ANTIBODIES, ANTI-CYCLIC CITRULLINATED PEPTIDE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ANTI-CCP; ANTIBODIES, ANTI-CYCLIC CITRULLINATED PEPTIDE Back to Search Results
Catalog Number 05031656190
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/26/2015
Event Type  malfunction  
Event Description
The customer questioned the anti-ccp result of 57.49 u/ml for this sample, tested on (b)(6) 2015, because there was a large difference between this result and the patient's result of 11300 u/ml from "last summer".It is not known if erroneous results were reported outside of the laboratory.The sample was tested undiluted and diluted.The anti-ccp result from the undiluted sample was 56.74 u/ml.The sample was then diluted with an anti-ccp negative serum pool and tested using multiple dilution.A 2- fold dilution of the sample gave a result of 80.37 u/ml.The sample was repeated with 5-fold dilution and the result was 131.0 u/ml.The sample was repeated with 10-fold dilution and the result was >132.5 u/ml.The sample was repeated with 20-fold dilution and the result was >132.5 u/ml.The sample was repeated with 50-fold dilution and the result was 120.8 u/ml.The sample was repeated with a 100-fold dilution and the result was 72.53 u/ml.No adverse event was reported.The elecsys modular e170 serial number was not provided.Two samples from the patient were sent in for investigation.The results could not be reproduced.A specific root cause could not be identified during the investigation.A general reagent lot issue can be excluded.Product labeling documents autoantibodies are heterogeneous and this can cause non-linear dilution phenomena for certain individual samples.In addition, a sample dilution was not necessary as the result was within the measuring range.Recommended dilution is 1:2 to 1:5.The sample was diluted up to 1:100.
 
Manufacturer Narrative
This event occurred in (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ANTI-CCP
Type of Device
ANTIBODIES, ANTI-CYCLIC CITRULLINATED PEPTIDE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 6830 5
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key4712109
MDR Text Key21187387
Report Number1823260-2015-03148
Device Sequence Number1
Product Code NHX
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K081338
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Health Professional
Type of Report Initial
Report Date 04/21/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number05031656190
Device Lot Number180711
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Event Location Laboratory
Initial Date Manufacturer Received 03/26/2015
Initial Date FDA Received04/21/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age081 YR
-
-